(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
10 day averaged volume of Arbutus Biopharma is 945671
| Date | Daily Closing Price | Open | High | Low | Volume |
| 15 Wed Oct 2025 | 4.47 | 4.24 | 4.48 | 4.22 | 0.872 times |
| 14 Tue Oct 2025 | 4.24 | 4.25 | 4.36 | 4.10 | 1.249 times |
| 13 Mon Oct 2025 | 4.28 | 4.15 | 4.30 | 4.10 | 0.758 times |
| 10 Fri Oct 2025 | 4.11 | 4.27 | 4.30 | 4.10 | 0.802 times |
| 09 Thu Oct 2025 | 4.27 | 4.15 | 4.31 | 4.10 | 1.291 times |
| 08 Wed Oct 2025 | 4.18 | 4.31 | 4.39 | 4.17 | 0.795 times |
| 07 Tue Oct 2025 | 4.29 | 4.37 | 4.54 | 4.28 | 1.16 times |
| 06 Mon Oct 2025 | 4.34 | 4.39 | 4.40 | 4.29 | 0.963 times |
| 03 Fri Oct 2025 | 4.38 | 4.52 | 4.53 | 4.30 | 0.944 times |
| 02 Thu Oct 2025 | 4.49 | 4.59 | 4.60 | 4.38 | 0.647 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 4.5 as stoploss in an intra day sell trade for a target of 4.37. However, stock will show a bullish move above 4.5.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 3.04 |
| Downside Target | 3.27 |
| Downside Target | 3.42 |
| Downside Target | 3.62 |
| Downside Target | 4.10 |
| Upside Target | 4.48 |
| Upside Target | 4.54 |
| Upside Target | 4.56 |
| Upside Target | 4.57 |
| Upside Target | 4.66 |
| Upside Target | 5.10 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 4.22 |
| Downside Intraday Target | 3.97 |
| Upside Intraday Target | 4.6 |
| Upside Intraday Target | 4.73 |
| Downside Intraday Target | 4.35 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 15 Wed Oct 2025 | 4.47 | 4.15 | 4.48 | 4.10 | 0.575 times |
| 10 Fri Oct 2025 | 4.11 | 4.39 | 4.54 | 4.10 | 0.964 times |
| 03 Fri Oct 2025 | 4.38 | 4.47 | 4.66 | 4.30 | 1.158 times |
| 26 Fri Sep 2025 | 4.41 | 4.25 | 4.56 | 4.25 | 0.668 times |
| 19 Fri Sep 2025 | 4.25 | 4.50 | 4.57 | 4.18 | 0.482 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 15 Wed Oct 2025 | 4.47 | 4.55 | 4.66 | 4.10 | 0.307 times |
| 30 Tue Sep 2025 | 4.54 | 3.69 | 5.10 | 3.66 | 1.917 times |
| 29 Fri Aug 2025 | 3.71 | 3.27 | 3.73 | 3.27 | 1.173 times |
| 31 Thu Jul 2025 | 3.28 | 3.07 | 3.42 | 3.06 | 0.953 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.3 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.3 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.